Search details
1.
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.
Mol Ther
; 31(11): 3290-3307, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37641403
2.
Charcot-Marie-Tooth neuropathies: Current gene therapy advances and the route toward translation.
J Peripher Nerv Syst
; 28(2): 150-168, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36965137
3.
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
J Peripher Nerv Syst
; 28(3): 329-340, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37220142
4.
Glial Gap Junction Pathology in the Spinal Cord of the 5xFAD Mouse Model of Early-Onset Alzheimer's Disease.
Int J Mol Sci
; 23(24)2022 Dec 09.
Article
in English
| MEDLINE | ID: mdl-36555237
5.
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
Gene Ther
; 28(10-11): 659-675, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33692503
6.
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
Int J Mol Sci
; 22(11)2021 Jun 03.
Article
in English
| MEDLINE | ID: mdl-34205075
7.
Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A.
Int J Mol Sci
; 22(21)2021 Oct 26.
Article
in English
| MEDLINE | ID: mdl-34769001
8.
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
Brain
; 142(5): 1227-1241, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30907403
9.
Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
Hum Mol Genet
; 26(9): 1622-1633, 2017 05 01.
Article
in English
| MEDLINE | ID: mdl-28334782
10.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Proc Natl Acad Sci U S A
; 113(17): E2421-9, 2016 Apr 26.
Article
in English
| MEDLINE | ID: mdl-27035961
11.
Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Glia
; 66(12): 2589-2603, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30325069
12.
Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.
Brain
; 140(3): 599-616, 2017 03 01.
Article
in English
| MEDLINE | ID: mdl-28100454
13.
Transgenic replacement of Cx32 in gap junction-deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Hum Mol Genet
; 24(7): 2049-64, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25524707
14.
Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
Ann Neurol
; 78(2): 303-16, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26010264
15.
Differential modulation of the juxtaparanodal complex in Multiple Sclerosis.
Mol Cell Neurosci
; 67: 93-103, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26070930
16.
A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32.
Neurogenetics
; 16(3): 193-200, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25771809
17.
Gene delivery targeted to oligodendrocytes using a lentiviral vector.
J Gene Med
; 16(11-12): 364-73, 2014.
Article
in English
| MEDLINE | ID: mdl-25394283
18.
Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy.
Mol Ther Methods Clin Dev
; 30: 377-393, 2023 Sep 14.
Article
in English
| MEDLINE | ID: mdl-37645436
19.
Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer's Disease.
Life (Basel)
; 13(5)2023 Apr 27.
Article
in English
| MEDLINE | ID: mdl-37240740
20.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Glia
; 60(7): 1053-66, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22461072